Yuflyma is approved across 13 indications for the treatment of multiple chronic inflammatory diseases

Surgeons who will work at new specialist mesh centres throughout England hope to establish their competence through credentialing […]

To study early stages in embryonic development in the cell culture dish, scientists use so-called human pluripotent stem […]

For the first time, engineered heart muscle (EHM) from human induced pluripotent stem cells (iPSCs) will be used […]

Get a structured handoverArafat Mulla, specialty trainee year 4 in respiratory medicine, North West deanery, says, “Be in […]

CureVac’s CVnCoV is currently being investigated in a randomised, placebo-controlled Phase IIb/III clinical trial

Accelerate@Babraham supports early-stage life sciences ventures within the Babraham Research Campus’ community

People aged 65 to 69 and the clinically vulnerable will be offered the jab from today

CDK4 & 6 inhibitor has been available as part of a Cancer Drugs Fund (CDF) managed access agreement

Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer […]